Literature DB >> 2926106

Epidemic bloodstream infections associated with pressure transducers: a persistent problem.

C M Beck-Sague1, W R Jarvis.   

Abstract

Twenty-four outbreaks of nosocomial bloodstream infection (BSI) were investigated by the Centers for Disease Control from Jan 1, 1977 to Dec 31, 1987. Intravascular pressure monitoring devices (transducers) were the most commonly identified source of bacterial and fungal BSI outbreaks and were implicated as the source of infection in eight (33%) outbreaks. These included outbreaks caused by Candida parapsilosis (2), Serratia marcescens (2), Klebsiella oxytoca (1), Pseudomonas cepacia (1), Acinetobacter calcoaceticus (1), and one polymicrobial bacteremia outbreak due to Acinetobacter, Pseudomonas, Citrobacter, and Enterobacter species. In all eight outbreaks, reusable transducers improperly disinfected or fitted with domes that had been improperly sterilized served as reservoirs for the organism. Compared with nosocomial BSI outbreaks not related to transducers, those in which transducers were implicated as a reservoir involved a larger mean number of patients (24 v 9; P = 0.007), and were significantly more likely to involve intensive care unit patients (23/24 v 3/9; P = 0.025) and to have a longer mean duration (11 v 3 months; P = 0.007). These findings show that the characteristics of transducer- and non-transducer-related BSI outbreaks differ, and that centers using intravascular pressure monitoring devices must be aware of and implement recommended infection control strategies for care and maintenance of these devices.

Entities:  

Mesh:

Year:  1989        PMID: 2926106     DOI: 10.1086/645961

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  11 in total

1.  Catheter-Related Bloodstream Infection.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

2.  Performance analysis of exam gloves used for aseptic rodent surgery.

Authors:  Dana M LeMoine; Valerie K Bergdall; Carrie Freed
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-05       Impact factor: 1.232

3.  Lytic myophage Abp53 encodes several proteins similar to those encoded by host Acinetobacter baumannii and phage phiKO2.

Authors:  Chia-Ni Lee; Tsai-Tien Tseng; Juey-Wen Lin; Yung-Chieh Fu; Shu-Fen Weng; Yi-Hsiung Tseng
Journal:  Appl Environ Microbiol       Date:  2011-08-05       Impact factor: 4.792

Review 4.  Serratia infections: from military experiments to current practice.

Authors:  Steven D Mahlen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

5.  Klebsiella oxytoca Complex: Update on Taxonomy, Antimicrobial Resistance, and Virulence.

Authors:  Jing Yang; Haiyan Long; Ya Hu; Yu Feng; Alan McNally; Zhiyong Zong
Journal:  Clin Microbiol Rev       Date:  2021-12-01       Impact factor: 50.129

Review 6.  Epidemiology of nosocomial infections in adult intensive care units.

Authors:  A Trilla
Journal:  Intensive Care Med       Date:  1994-07       Impact factor: 17.440

7.  Pressure transducers: an overlooked source of sepsis in the intensive care unit.

Authors:  T A Hekker; W van Overhagen; A J Schneider
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

8.  Epidemic of Serratia marcescens bacteremia in a cardiac intensive care unit.

Authors:  M E Villarino; W R Jarvis; C O'Hara; J Bresnahan; N Clark
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

Review 9.  Clinical review: complications and risk factors of peripheral arterial catheters used for haemodynamic monitoring in anaesthesia and intensive care medicine.

Authors:  Bernd Scheer; Azriel Perel; Ulrich J Pfeiffer
Journal:  Crit Care       Date:  2002-04-18       Impact factor: 9.097

10.  A multicenter surveillance of antimicrobial resistance in Serratia marcescens in Taiwan.

Authors:  Bo-Huang Liou; Ruay-Wang Duh; Yi-Tsung Lin; Tsai-Ling Yang Lauderdale; Chang-Phone Fung
Journal:  J Microbiol Immunol Infect       Date:  2013-06-14       Impact factor: 4.399

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.